Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in senescence

A novel molecular target against age-related diseases

D. Lauro, D. Pastore, B. Capuani, F. Pacifici, R. Palmirotta, P. Abete, M. Roselli, A. Bellia, M. Federici, N. Di Daniele, P. Sbraccia, F. Guadagni, R. Lauro, D. Della-Morte

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Senescence is a phenomenon characterized by a progressive decline of body homeostasis. Premature senescence acts when the cellular system is not able to adequately respond to noxious stimuli by synthesis of stressor molecules. Among those, serum-and-glucocorticoidinducible kinase-1 (SGK-1) dramatically increases under typical physiopathological conditions, such as glucocorticoid or mineralcorticoids exposure, inflammation, hyperglycemia, and ischemia. SGK-1 has been implicated in mechanism regulating oxidative stress, apoptosis, and DNA damage, which are all leading to a state of accelerating aging. Moreover, SGK-1-sensitive ion channels participate in the regulation of renal Na+/K+ regulation, blood pressure, gastric acid secretion, cardiac action potential, and neuroexcitability. Recently, we demonstrated in endothelial cells as an increase in SGK-1 activity and expression reduces oxidative stress, improves cell survival and restores insulin-mediated nitric oxide production after hyperglycemia. Moreover, we showed as SGK-1 delays the onset of senescence by increasing telomerase activity, significantly decreasing reactive oxygen species (ROS) production, and by directly interacting with hTERT. Therefore, SGK-1 may represent a specific target to further develop novel therapeutic options against chronic diseases such as diabetes typical of aging. SGK-1 has been also associated with cancer, neurodegenerative diseases, and cardiovascular disease, among other age-related diseases. However, to date, the data available on SGK-1 and aging, are sparse, controversial, and only from C. elegans experimental models. In this review we sought to discuss the possible implication of SGK-1 in mechanisms regulating senescence and age-related diseases. Moreover, we aimed to discuss and identify the possible role of SGK-1 as possible molecular target to counteract and prevent aging.

Original languageEnglish
Pages (from-to)3765-3788
Number of pages24
JournalCurrent Medicinal Chemistry
Volume22
Issue number33
Publication statusPublished - Dec 1 2015

Fingerprint

Glucocorticoids
Phosphotransferases
Aging of materials
Oxidative stress
Hyperglycemia
Oxidative Stress
serum-inducible kinase
Neurodegenerative diseases
Telomerase
Gastric Acid
Endothelial cells
Blood pressure
Medical problems
Ion Channels
Neurodegenerative Diseases
Action Potentials
DNA Damage
Reactive Oxygen Species
Cell Survival
Nitric Oxide

Keywords

  • Aging
  • Apoptosis
  • Cancer
  • Inflammation
  • Metabolic diseases
  • Oxidative stress
  • SGK-1

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in senescence : A novel molecular target against age-related diseases. / Lauro, D.; Pastore, D.; Capuani, B.; Pacifici, F.; Palmirotta, R.; Abete, P.; Roselli, M.; Bellia, A.; Federici, M.; Di Daniele, N.; Sbraccia, P.; Guadagni, F.; Lauro, R.; Della-Morte, D.

In: Current Medicinal Chemistry, Vol. 22, No. 33, 01.12.2015, p. 3765-3788.

Research output: Contribution to journalArticle

Lauro, D, Pastore, D, Capuani, B, Pacifici, F, Palmirotta, R, Abete, P, Roselli, M, Bellia, A, Federici, M, Di Daniele, N, Sbraccia, P, Guadagni, F, Lauro, R & Della-Morte, D 2015, 'Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in senescence: A novel molecular target against age-related diseases', Current Medicinal Chemistry, vol. 22, no. 33, pp. 3765-3788.
Lauro D, Pastore D, Capuani B, Pacifici F, Palmirotta R, Abete P et al. Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in senescence: A novel molecular target against age-related diseases. Current Medicinal Chemistry. 2015 Dec 1;22(33):3765-3788.
Lauro, D. ; Pastore, D. ; Capuani, B. ; Pacifici, F. ; Palmirotta, R. ; Abete, P. ; Roselli, M. ; Bellia, A. ; Federici, M. ; Di Daniele, N. ; Sbraccia, P. ; Guadagni, F. ; Lauro, R. ; Della-Morte, D. / Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in senescence : A novel molecular target against age-related diseases. In: Current Medicinal Chemistry. 2015 ; Vol. 22, No. 33. pp. 3765-3788.
@article{697c52c6aada4d928c2afaec29b69ff0,
title = "Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in senescence: A novel molecular target against age-related diseases",
abstract = "Senescence is a phenomenon characterized by a progressive decline of body homeostasis. Premature senescence acts when the cellular system is not able to adequately respond to noxious stimuli by synthesis of stressor molecules. Among those, serum-and-glucocorticoidinducible kinase-1 (SGK-1) dramatically increases under typical physiopathological conditions, such as glucocorticoid or mineralcorticoids exposure, inflammation, hyperglycemia, and ischemia. SGK-1 has been implicated in mechanism regulating oxidative stress, apoptosis, and DNA damage, which are all leading to a state of accelerating aging. Moreover, SGK-1-sensitive ion channels participate in the regulation of renal Na+/K+ regulation, blood pressure, gastric acid secretion, cardiac action potential, and neuroexcitability. Recently, we demonstrated in endothelial cells as an increase in SGK-1 activity and expression reduces oxidative stress, improves cell survival and restores insulin-mediated nitric oxide production after hyperglycemia. Moreover, we showed as SGK-1 delays the onset of senescence by increasing telomerase activity, significantly decreasing reactive oxygen species (ROS) production, and by directly interacting with hTERT. Therefore, SGK-1 may represent a specific target to further develop novel therapeutic options against chronic diseases such as diabetes typical of aging. SGK-1 has been also associated with cancer, neurodegenerative diseases, and cardiovascular disease, among other age-related diseases. However, to date, the data available on SGK-1 and aging, are sparse, controversial, and only from C. elegans experimental models. In this review we sought to discuss the possible implication of SGK-1 in mechanisms regulating senescence and age-related diseases. Moreover, we aimed to discuss and identify the possible role of SGK-1 as possible molecular target to counteract and prevent aging.",
keywords = "Aging, Apoptosis, Cancer, Inflammation, Metabolic diseases, Oxidative stress, SGK-1",
author = "D. Lauro and D. Pastore and B. Capuani and F. Pacifici and R. Palmirotta and P. Abete and M. Roselli and A. Bellia and M. Federici and {Di Daniele}, N. and P. Sbraccia and F. Guadagni and R. Lauro and D. Della-Morte",
year = "2015",
month = "12",
day = "1",
language = "English",
volume = "22",
pages = "3765--3788",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "33",

}

TY - JOUR

T1 - Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in senescence

T2 - A novel molecular target against age-related diseases

AU - Lauro, D.

AU - Pastore, D.

AU - Capuani, B.

AU - Pacifici, F.

AU - Palmirotta, R.

AU - Abete, P.

AU - Roselli, M.

AU - Bellia, A.

AU - Federici, M.

AU - Di Daniele, N.

AU - Sbraccia, P.

AU - Guadagni, F.

AU - Lauro, R.

AU - Della-Morte, D.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Senescence is a phenomenon characterized by a progressive decline of body homeostasis. Premature senescence acts when the cellular system is not able to adequately respond to noxious stimuli by synthesis of stressor molecules. Among those, serum-and-glucocorticoidinducible kinase-1 (SGK-1) dramatically increases under typical physiopathological conditions, such as glucocorticoid or mineralcorticoids exposure, inflammation, hyperglycemia, and ischemia. SGK-1 has been implicated in mechanism regulating oxidative stress, apoptosis, and DNA damage, which are all leading to a state of accelerating aging. Moreover, SGK-1-sensitive ion channels participate in the regulation of renal Na+/K+ regulation, blood pressure, gastric acid secretion, cardiac action potential, and neuroexcitability. Recently, we demonstrated in endothelial cells as an increase in SGK-1 activity and expression reduces oxidative stress, improves cell survival and restores insulin-mediated nitric oxide production after hyperglycemia. Moreover, we showed as SGK-1 delays the onset of senescence by increasing telomerase activity, significantly decreasing reactive oxygen species (ROS) production, and by directly interacting with hTERT. Therefore, SGK-1 may represent a specific target to further develop novel therapeutic options against chronic diseases such as diabetes typical of aging. SGK-1 has been also associated with cancer, neurodegenerative diseases, and cardiovascular disease, among other age-related diseases. However, to date, the data available on SGK-1 and aging, are sparse, controversial, and only from C. elegans experimental models. In this review we sought to discuss the possible implication of SGK-1 in mechanisms regulating senescence and age-related diseases. Moreover, we aimed to discuss and identify the possible role of SGK-1 as possible molecular target to counteract and prevent aging.

AB - Senescence is a phenomenon characterized by a progressive decline of body homeostasis. Premature senescence acts when the cellular system is not able to adequately respond to noxious stimuli by synthesis of stressor molecules. Among those, serum-and-glucocorticoidinducible kinase-1 (SGK-1) dramatically increases under typical physiopathological conditions, such as glucocorticoid or mineralcorticoids exposure, inflammation, hyperglycemia, and ischemia. SGK-1 has been implicated in mechanism regulating oxidative stress, apoptosis, and DNA damage, which are all leading to a state of accelerating aging. Moreover, SGK-1-sensitive ion channels participate in the regulation of renal Na+/K+ regulation, blood pressure, gastric acid secretion, cardiac action potential, and neuroexcitability. Recently, we demonstrated in endothelial cells as an increase in SGK-1 activity and expression reduces oxidative stress, improves cell survival and restores insulin-mediated nitric oxide production after hyperglycemia. Moreover, we showed as SGK-1 delays the onset of senescence by increasing telomerase activity, significantly decreasing reactive oxygen species (ROS) production, and by directly interacting with hTERT. Therefore, SGK-1 may represent a specific target to further develop novel therapeutic options against chronic diseases such as diabetes typical of aging. SGK-1 has been also associated with cancer, neurodegenerative diseases, and cardiovascular disease, among other age-related diseases. However, to date, the data available on SGK-1 and aging, are sparse, controversial, and only from C. elegans experimental models. In this review we sought to discuss the possible implication of SGK-1 in mechanisms regulating senescence and age-related diseases. Moreover, we aimed to discuss and identify the possible role of SGK-1 as possible molecular target to counteract and prevent aging.

KW - Aging

KW - Apoptosis

KW - Cancer

KW - Inflammation

KW - Metabolic diseases

KW - Oxidative stress

KW - SGK-1

UR - http://www.scopus.com/inward/record.url?scp=84959517009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959517009&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 3765

EP - 3788

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 33

ER -